Quantcast

Latest COX-2 inhibitors Stories

2014-06-02 08:29:10

Mylan will launch all strengths at earliest market formation PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into a settlement and license agreement with Pfizer Inc. relating to Mylan's Abbreviated New Drug Application (ANDA) filed with the U.S. Food and Drug Administration (FDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg. This product is the generic version of Celebrex(®), which is indicated for the relief of the...

2014-05-30 12:26:11

Expects to Imminently Receive Final Approval on 50 mg Strength; Has Received Tentative Approval on All Strengths PITTSBURGH, May 30, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today commented on the decision by the United States District Court for the Northern District of West Virginia denying Mylan's request for an injunction in its suit against the U.S. Food and Drug Administration (FDA), challenging the agency's decision regarding generic drug marketing exclusivity on Celecoxib...

FDA Approves Several Drugs That Predictably Increase Risk For Heart And Stroke
2014-05-28 03:41:30

By Jeannette Spalding, Case Western Reserve University The agency charged to protect patients from dangerous drug side effects needs to be far more vigilant when it comes to medications that affect blood pressure. Robert P. Blankfield, MD, MS, a clinical professor of family medicine, issues this call to the U.S. Food and Drug Administration (FDA) in an editorial published recently in an online edition of the Journal of Cardiovascular Pharmacology and Therapeutics; the print version of...

2014-03-13 08:28:09

PITTSBURGH, March 13, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the United States District Court for the Eastern District of Virginia has ruled invalid a patent, United States Patent No. RE44,048, related to Pfizer's Celebrex® (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules. Mylan was sued by G.D. Searle LLC and Pfizer Asia Pacific PTE, Ltd. for alleged infringement of this patent in connection with Mylan's Abbreviated New Drug Application (ANDA) for...

Continued Use Of Some Painkillers Can Raise Heart Risks
2013-05-30 11:48:18

Michael Harper for redOrbit.com — Your Universe Online A new study conducted by researchers at the University of Oxford has found that common painkillers can slightly increase the risk of heart problems in the long run. Common medications, such as ibuprofen and diclofenac were specifically noted in the study as being “equally dangerous” as Vioxx, a drug which has been removed from the market in the US due to its potentially dangerous effects. The Oxford researchers...

2013-05-18 23:04:28

The personal injury law firm of d´Oliveira & Associates has issued an infographic on Stevens Johnson Syndrome, which details potential causes and serious conditions that may result from the syndrome. (PRWEB) May 18, 2013 According to the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), also known as Toxic Epidermal Necrolysis, is a severe allergic reaction usually to medicine (i). The first signs of SJS involve flu-like symptoms but it can quickly advance...

shutterstock_106831472
2012-09-11 21:38:41

Lee Rannals for redOrbit.com — Your Universe Online Taking painkillers increases your risk of death if you are a heart attack survivor, according to a study published in the journal Circulation. Scientists found that those heart attack survivors who take painkillers not only increased their chances of having a second heart attack, but also increased their risk of dying. Over-the-counter painkillers like ibuprofen and naproxen, as well as prescription drugs like Celebrex, are...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.